The Niche - Knoepfler lab stem cell blog

Sara Sheehan, Mark Berman stem cell docuseries

Loring on how documentary tied to stem cell clinics began to unravel

June 23, 2019 Paul Knoepfler 0

By Jeanne Loring There has been news over the last few days about stem cell researchers pulling out from a documentary called “The Healthcare Revolution”. First to report on June 15 was Erin Allday of the San Francisco Chronicle, followed […]

StemGenex, unproven clinic sued by patients, morphs into Advanced Cell Medicine?

June 19, 2019 Paul Knoepfler 2

The unproven stem cell clinic StemGenex appears to now be called Advanced Cell Medicine. StemGenex is facing a proposed class action lawsuit by patients and it also recently received an FDA warning letter. StemGenex is notable too in that it […]

Muddy waters: stem cell clinic calls itself CIRM & docuseries sparks controversy

June 16, 2019 Paul Knoepfler 7

We’re seeing more muddy waters in the stem cell universe. A chiropractic stem cell and alternative medicine clinic has popped up calling itself, of all things, CIRM. On another front, an already controversial docuseries set to air tomorrow combines interviews […]

Ben Greenfield US Stem Cell DIY stem cell administration

Stunning video of DIY self-injection of apparent US Stem Cell product posted after court loss

June 12, 2019 Paul Knoepfler 3

A fitness guru named Ben Greenfield has now reported self-injecting non-FDA approved stem cells. He says the stem cells came from a clinic that lost a big federal court case 9 days ago. Greenfield posted a Facebook video of the […]

About that Captain Kirk ‘stem cell treatment’

June 9, 2019 Paul Knoepfler 5

When we mix celebrities like William Shatner who played Captain Kirk on the original Star Trek series with stem cells, things usually end badly. For this reason when I read that Shatner had gotten a supposed stem cell treatment, I […]

The mission of the Knoepfler Lab Blog here at UC Davis School of Medicine is to build stem cell bridges to new treatments and cures through education, outreach, and science.

I encourage readers of this blog to make comments.

There are some rules and key considerations for ipscell.com governing the comments to keep in mind.

Comments will be moderated by a really busy human being so they may not appear right away, particularly if they are long and/or contain allegations against people or companies, or express inflammatory opinions in which case they may take up to a day or longer to appear or may never appear.
Comments cannot include personal attacks.
Commenters should avoid being libelous to a person or corporation.
Commenters must use a valid email address.
Commenters generally cannot promote a specific unproven stem cell clinic or physician even by implication.
Commenters are solely responsible for the content of their comments.
I generally do not post comments written by parties referring to other parties who are both involved in an ongoing or pending legal dispute with each other such as litigation. Exceptions to this may be allowed for comments on a blog post that has a topic focused specifically on said legal disputes.
Commenters cannot give medical advice.
Consumers posting comments regarding their opinions of medical treatment they received are solely responsible for that content and readers should understand that such comments reflect opinions, not facts.
Commenters who violate this policy with their submitted comments may temporarily or permanently lose the right to make comments.

By submitting your comment for potential posting on this blog you agree that the comment may be either edited or not posted at all at the blog's discretion if there is concern about non-compliance with this comment policy.

Disclosures

The views expressed on this blog in posts are my own and do not reflect the views of my employer, UC Davis.

I have no financial interests in any stem cell companies or patents in that area.

No material on this website should be considered medical advice and all medical decisions should be discussed with your personal physician first.